MECP2 Isoform-Specific Vectors with Regulated Expression for Rett Syndrome Gene TherapyMojgan Rastegar, James Ellis|PLoS ONE|2009Cited by 77
Preclinical target validation using patient-derived cellsA.M. Edwards, Kevin Petrecca, Dhavalkumar D. Patel et al.|Nature Reviews Drug Discovery|2015Cited by 54
Buffering of transcription rate by mRNA half-life is a conserved feature of Rett syndrome modelsDeivid C. Rodrigues, James Ellis|Nature Communications|2023Cited by 12